USD 0.03
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 943.17 Thousand USD | 38.36% |
2022 | 681.7 Thousand USD | 313.56% |
2021 | 164.83 Thousand USD | -67.14% |
2020 | 501.71 Thousand USD | -75.82% |
2019 | 2.07 Million USD | 94.31% |
2018 | 1.06 Million USD | -16.19% |
2017 | 1.27 Million USD | 117.54% |
2016 | 585.76 Thousand USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 1.04 Million USD | 10.75% |
2023 Q1 | 738.05 Thousand USD | 8.27% |
2023 Q4 | 943.17 Thousand USD | -17.05% |
2023 Q3 | 1.13 Million USD | 37.08% |
2023 Q2 | 829.46 Thousand USD | 12.39% |
2023 FY | 943.17 Thousand USD | 38.36% |
2022 Q3 | 290.6 Thousand USD | 40.62% |
2022 Q1 | 181.31 Thousand USD | 9.99% |
2022 FY | 681.7 Thousand USD | 313.56% |
2022 Q4 | 681.7 Thousand USD | 134.58% |
2022 Q2 | 206.65 Thousand USD | 13.98% |
2021 Q3 | 441.84 Thousand USD | -85.83% |
2021 FY | 164.83 Thousand USD | -67.14% |
2021 Q2 | 3.11 Million USD | 6.93% |
2021 Q1 | 2.91 Million USD | 12.83% |
2021 Q4 | 164.83 Thousand USD | -62.69% |
2020 Q4 | 2.58 Million USD | 0.0% |
2020 FY | 501.71 Thousand USD | -75.82% |
2019 FY | 2.07 Million USD | 94.31% |
2018 FY | 1.06 Million USD | -16.19% |
2017 Q4 | 1274.28 USD | 0.0% |
2017 FY | 1.27 Million USD | 117.54% |
2016 FY | 585.76 Thousand USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
American Medical Technologies Inc. | 2.34 Million USD | 59.862% |
Ansell Limited | 1.32 Billion USD | 99.929% |
Ansell Limited | 1.33 Billion USD | 99.929% |
BG Medicine, Inc. | - USD | -Infinity% |
Biotage AB (publ) | 126.33 Million USD | 99.253% |
BioLife Sciences Inc. | - USD | -Infinity% |
Psykey, Inc. | 2.47 Million USD | 61.877% |
ConvaTec Group Plc | 2.01 Billion USD | 99.953% |
ConvaTec Group Plc | 2.02 Billion USD | 99.953% |
Encision Inc. | 1.98 Million USD | 52.46% |
Golden Valley Development, Inc | - USD | -Infinity% |
Hear AtLast Holdings, Inc. | 3.04 Million USD | 68.979% |
Innovative MedTech Inc. | 6.13 Million USD | 84.626% |
LifePoint, Inc. | 2.45 Million USD | 61.569% |
Medite Cancer Diagnostics, Inc. | 10.18 Million USD | 90.736% |
Paradigm Medical Industries, Inc. | 3.4 Million USD | 72.26% |
QuantRx Biomedical Corporation | - USD | -Infinity% |
Remedent, Inc. | 3.04 Million USD | 68.978% |
Reflect Scientific, Inc. | 776.32 Thousand USD | -21.491% |
SmileDirectClub, Inc. | 982.26 Million USD | 99.904% |
Sector 10, Inc. | 9.84 Million USD | 90.42% |
Shandong Weigao Group Medical Polymer Company Limited | 1.35 Billion USD | 99.93% |
SheerVision, Inc. | 1.43 Million USD | 34.109% |
United Health Products, Inc. | 1.99 Million USD | 52.815% |
Vasamed, Inc. | 1 Million USD | 6.18% |
Wearable Health Solutions, Inc. | 3.8 Million USD | 75.182% |
Yubo International Biotech Limited | 2.91 Million USD | 67.632% |